24-24 April 2023
keyboard_arrow_left See all news

Recent News

10 Jan, 2023 /
Qosina introduces Irradiate to Order service for single-use bioprocess components
Qosina introduces an Irradiate to Order service for its single-use bioprocess component ...
09 Jan, 2023 /
Qosina Announces Partnership with ILC Dover and Expanded Portfolio of Liquid Bag Chambers
Qosina announces a partnership with ILC Dover, a leader in the innovative design and pro...
05 Jan, 2023 /
Life Science Outsourcing, Inc.
Life Science Outsourcing Completes Acquisition of J-Pac Medical
Expands into biomaterials and diagnostics end-markets, broadens service offerings, and s...
04 Jan, 2023 /
Qosina introduces AseptiQuik® G DC Series Connectors
Qosina announces the addition of the AseptiQuik® G DC Series connectors to its extensiv...
17 Nov, 2022 /
PTI Engineered Plastics, Inc.
PTI Engineered Plastics Receives MedAccred® Plastics Continuing Accreditation
PTI Engineered Plastics recognized for its commitment to continual improvement in medica...
Phillips-Medisize, a Molex company
/ 09 Apr, 2019
keyboard_arrow_left See all news

Phillips-Medisize Opens New Facility in China

HUDSON, WI – May 17, 2018 – phillipsmedisize – Phillips-Medisize, a Molex company, has announced a significant company expansion in Suzhou, China. The company has added approximately 140,000 sq. ft. (13,000 sq. m.) of medical manufacturing space near the company's existing site, expanding not only the company's manufacturing abilities and capacity in China, but also the design and development services as well.

Phillips-Medisize will manufacture both drug delivery and medical devices at the facility, which is slated to begin production next month. The state-of-the-art facility will also offer clean room molding and clean room assembly. The new Suzhou site will be fully integrated with other Phillips-Medisize sites around the globe, providing common worldwide quality standards and design controls, along with local service and manufacturing support. Additionally, Phillips-Medisize's continuum of services, coupled with the vertical integration of Molex's electronics, provides comprehensive end-to-end Connected Health solutions.“The expansion confirms the ‘Asia for Asia' strategy we announced four years ago, as we continue to see significant growth and demand of customers in this region,” remarked Matt Jennings, President Phillips-Medisize. “This expansion builds on Phillips-Medisize's already-strong reputation for manufacturing excellence and expertise, ensuring that customers in Asia are able to take advantage of the same capabilities and services that are available in the United States and Europe.”This will be the company's seventh expansion in the past six years to support long-term growth of its medical contract development and manufacturing business. These investments demonstrate ongoing support for biopharmaceutical and medtech customers by providing design, development and manufacturing solutions for both mechanical and connected devices across multiple geographies.

Processing. Please wait.